SkylineDx Announces Data from Largest Prospective Multi-Center Melanoma Gene Expression Profiling Trial at 21st International Congress of the Society for Melanoma Research ...Middle East

PR Newswire - News
The Merlin test (CP-GEP) stratifies melanoma patients based on risk for sentinel lymph node (SLN) metastasis, offering a powerful tool for risk-based decision-making. ROTTERDAM, Netherlands and SAN DIEGO, Oct. 13, 2024 /PRNewswire/ -- SkylineDx, an innovative diagnostics company...

Hence then, the article about skylinedx announces data from largest prospective multi center melanoma gene expression profiling trial at 21st international congress of the society for melanoma research was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SkylineDx Announces Data from Largest Prospective Multi-Center Melanoma Gene Expression Profiling Trial at 21st International Congress of the Society for Melanoma Research )

Apple Storegoogle play

Last updated :

Also on site :